Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.04B |
| 2 |
Verizon
VZ
|
+$459M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$448M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$738M |
| 2 |
iShares MBS ETF
MBB
|
+$390M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$216M |
| 4 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$202M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.49% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Southside Bancshares
SBSI
$967M
| $11.2M | ﹤0.01% |
311,179
+12,964
| +4% | +$460K |
|
|
RVNC
1802
DELISTED
Revance Therapeutics, Inc.
RVNC
| $11.2M | ﹤0.01% |
606,618
+38,059
| +7% | +$871K |
|
1803
Metallus
MTUS
$838M
| $11.2M | ﹤0.01% |
614,985
+43,030
| +8% | +$764K |
|
1804
Dine Brands
DIN
$456M
| $11.2M | ﹤0.01% |
172,782
-1,093
| -0.6% | -$76.1K |
|
1805
Adeia
ADEA
$2.94B
| $11.1M | ﹤0.01% |
1,170,221
-3,001,958
| -72% | -$30.5M |
|
1806
Standard Motor Products
SMP
$851M
| $11.1M | ﹤0.01% |
318,197
+16,543
| +5% | +$605K |
|
1807
PetMed Express
PETS
$41.7M
| $11M | ﹤0.01% |
623,726
+51,021
| +9% | +$1.01M |
|
1808
John B. Sanfilippo & Son
JBSS
$967M
| $11M | ﹤0.01% |
135,617
+2,386
| +2% | +$194K |
|
1809
Flywire
FLYW
$1.98B
| $11M | ﹤0.01% |
450,048
+15,680
| +4% | +$338K |
|
1810
Columbus McKinnon
CMCO
$553M
| $10.9M | ﹤0.01% |
336,250
+20,669
| +7% | +$611K |
|
1811
Acco Brands
ACCO
$389M
| $10.9M | ﹤0.01% |
1,951,078
+138,448
| +8% | +$719K |
|
1812
Telephone and Data Systems
TDS
$3.82B
| $10.9M | ﹤0.01% |
1,037,575
+43,664
| +4% | +$540K |
|
1813
AdaptHealth
AHCO
$1.47B
| $10.9M | ﹤0.01% |
566,003
+15,684
| +3% | +$332K |
|
|
VIVO
1814
DELISTED
Meridian Bioscience Inc
VIVO
| $10.9M | ﹤0.01% |
327,235
+7,847
| +2% | +$253K |
|
1815
Malibu Boats
MBUU
$541M
| $10.8M | ﹤0.01% |
203,044
+15,717
| +8% | +$843K |
|
1816
V2X
VVX
$2.83B
| $10.8M | ﹤0.01% |
261,792
+3,522
| +1% | +$140K |
|
1817
Tompkins Financial
TMP
$1.43B
| $10.8M | ﹤0.01% |
139,107
+3,470
| +3% | +$276K |
|
|
KYNB
1818
Kyntra Bio
KYNB
$27.2M
| $10.7M | ﹤0.01% |
26,739
+575
| +2% | +$220K |
|
1819
A10 Networks
ATEN
$2.13B
| $10.7M | ﹤0.01% |
643,954
-1,343
| -0.2% | -$23K |
|
|
CLDT
1820
Chatham Lodging
CLDT
$622M
| $10.7M | ﹤0.01% |
870,859
-18,478
| -2% | -$228K |
|
1821
nCino
NCNO
$2.02B
| $10.7M | ﹤0.01% |
403,692
+9,388
| +2% | +$264K |
|
1822
Liberty Latin America Class C
LILAK
$1.63B
| $10.7M | ﹤0.01% |
1,542,782
+37,026
| +2% | +$253K |
|
1823
Genesco
GCO
$425M
| $10.6M | ﹤0.01% |
230,213
-4,826
| -2% | -$219K |
|
1824
Construction Partners
ROAD
$5.84B
| $10.6M | ﹤0.01% |
396,249
+24,603
| +7% | +$705K |
|
1825
US Physical Therapy
USPH
$1.2B
| $10.5M | ﹤0.01% |
129,305
+3,177
| +3% | +$267K |
|
Similar funds
Charles Schwab's Q4 2022 Portfolio in Review
As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
- Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
- Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
- Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
- Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
- Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.
Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.